focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarlowe Regulatory News (MRL)

Share Price Information for Marlowe (MRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 524.00
Bid: 520.00
Ask: 530.00
Change: 0.00 (0.00%)
Spread: 10.00 (1.923%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 524.00
MRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

22 Feb 2021 17:20

RNS Number : 9532P
Marlowe PLC
22 February 2021
 

22 February 2021

Marlowe plc

("Marlowe" or the "Group")

 

Director/PDMR Shareholding

 

Marlowe plc ("Marlowe" or the "Group"), the specialist services group focused on developing companies which assure safety and regulatory compliance, notifies that in order to effect a transfer between legal holdings, Alex Dacre (Chief Executive of the Group) and Charles Skinner (Non-Executive Director) sold the following ordinary shares of 50 pence each in the capital of the Group ("Ordinary Shares").

 

On 19 February 2021, Alex Dacre sold 2,459,738 Ordinary Shares to Dacre Holdings Limited, a company wholly owned and controlled by Mr Dacre, at a price of 715 pence per Ordinary Share.

 

There is no change to Mr Dacre's beneficial interest in Ordinary Shares as a result of this transaction. Mr Dacre holds a beneficial interest in a total of 5,094,352 Ordinary Shares (representing c.8.2 per cent. of the Group's issued share capital).

 

On 22 February 2021, Charles Skinner sold 471,751 Ordinary Shares to Friary Holdings Limited, a company wholly owned and controlled by Mr Skinner, at a price of 710 pence per Ordinary Share.

 

There is no change to Mr Skinner's beneficial interest in Ordinary Shares as a result of this transaction. Mr Skinner holds a beneficial interest in a total of 805,084 Ordinary Shares (representing c.1.3 per cent. of the Group's issued share capital).

 

 

 

For further information:

www.marloweplc.com

 

 

Marlowe plc

0203 813 8498

Alex Dacre, Chief Executive

IR@marloweplc.com

Mark Adams, Group Finance Director

 

 

 

Cenkos Securities (Nominated Adviser & Joint Broker)

0207 397 8900

Nicholas Wells

Ben Jeynes

 

 

 

 

Joh. Berenberg, Gossler & Co. KG, London Branch (Joint Broker)

Ben Wright

Mark Whitmore

 

FTI Consulting

0203 207 7800

 

 

 

0203 727 1340

Nick Hasell

 

Alex Le May

 

 

 

 

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. Alex Dacre

2. Charles Skinner

2

Reason for the notification

a)

Position/status

1. Chief Executive

2. Non-Executive Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marlowe plc

b)

LEI

213800ZWSR4SBOM6B608

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 50 pence each

Identification code

ISIN: GB00BD8SLV43

b)

Nature of the transaction

Sale of ordinary shares to effect transfer between legal holdings

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

1. 715 pence

1. 2,459,738

 

 

 

2. 710 pence

2. 471,751

 

 

 

 

 

 

d)

 

Aggregated information

 

- Aggregated volume

1. 2,459,738 2. 471,751

- Price

1. £17,587,126.70 2. £3,349,432.10

e)

Date of the transaction

1. 19 February 2021

2. 22 February 2021

f)

Place of the transaction

Outside trading venue

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. Dacre Holdings Limited

2. Friary Holdings Limited

2

Reason for the notification

a)

Position/status

1. Person closely associated with Alex Dacre, Chief Executive

2. Person closely associated with Charles Skinner, Non-Executive Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marlowe plc

b)

LEI

213800ZWSR4SBOM6B608

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 50 pence each

Identification code

ISIN: GB00BD8SLV43

b)

Nature of the transaction

Purchase of ordinary shares to effect transfer between legal holdings

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

1. 715 pence

1. 2,459,738

 

 

 

2. 710 pence

2. 471,751

 

 

 

 

 

 

d)

 

Aggregated information

 

- Aggregated volume

1. 2,459,738 2. 471,751

- Price

1. £17,587,126.70 2. £3,349,432.10

e)

Date of the transaction

1. 19 February 2021

2. 22 February 2021

f)

Place of the transaction

Outside trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHMZGZZNZRGMZM
Date   Source Headline
14th Oct 20223:12 pmRNSHolding(s) in Company
11th Oct 20221:40 pmRNSHolding(s) in Company
10th Oct 20222:06 pmRNSHolding(s) in Company
21st Sep 20224:18 pmRNSHolding(s) in Company
20th Sep 20222:02 pmRNSHolding(s) in Company
14th Sep 202211:56 amRNSResult of Annual General Meeting
14th Sep 20227:00 amRNSAGM Statement
2nd Sep 20229:41 amRNSHolding(s) in Company
30th Aug 20227:00 amRNSLaunch of Group 2022 SAYE Scheme
16th Aug 20223:38 pmRNSExercise of Share Options and Total Voting Rights
9th Aug 20227:00 amRNSPublication of Notice of AGM and Annual Report
8th Aug 20227:00 amRNSChange of Auditor
7th Jul 20225:14 pmRNSDirector/PDMR Shareholding
5th Jul 20222:24 pmRNSExercise of Share Options and Total Voting Rights
4th Jul 20223:54 pmRNSExercise of Share Options and Total Voting Rights
4th Jul 20222:10 pmRNSDirector/PDMR Shareholding
1st Jul 20227:00 amRNSPublication of Annual Report
28th Jun 20227:00 amRNSFinal Results
23rd Jun 20227:00 amRNSNotice of Full Year Results Analyst Presentation
8th Jun 20227:00 amRNSAcquisition of HR Solutions
25th May 20227:00 amRNSAcquisition of Cedrec Information Systems Limited
23rd May 202212:55 pmRNSExercise of Share Options and Total Voting Rights
28th Apr 20224:22 pmRNSHolding(s) in Company
28th Apr 20224:18 pmRNSHolding(s) in Company
26th Apr 20224:36 pmRNSExercise of Share Options and Total Voting Rights
19th Apr 20227:00 amRNSAcquisition of TP Health
11th Apr 202210:47 amRNSExercise of Share Options
5th Apr 20223:05 pmRNSCapital Markets Day Replay
5th Apr 20227:00 amRNSCapital Markets Day
22nd Mar 20227:00 amRNSAcquisition of Griffin Fire
21st Mar 20227:00 amRNSNotice of Capital Markets Day and Trading Update
15th Mar 20227:00 amRNSAppointment of Joint Corporate Broker
17th Feb 20227:00 amRNSDirectorate Change
11th Feb 20227:00 amRNSAcquisition of S F Fire Limited
10th Feb 20227:00 amRNSNew Enlarged Debt Facility
31st Jan 202212:20 pmRNSHolding(s) in Company
28th Jan 20222:19 pmRNSDirector/PDMR Shareholding
27th Jan 20229:07 amRNSHolding(s) in Company
26th Jan 202211:39 amRNSDirector/PDMR Shareholding
26th Jan 20227:00 amRNSIssue of Equity and Total Voting Rights
21st Jan 20221:08 pmRNSHolding(s) in Company
20th Jan 20224:08 pmRNSResults of Placing
20th Jan 20227:48 amRNSProposed Placing and Acquisition of Optima Health
20th Jan 20227:00 amRNSAcquisition of Optima Health
19th Jan 202212:13 pmRNSAppointment of Independent Non-Executive Director
14th Jan 20225:01 pmRNSExercise of Share Options
20th Dec 20217:00 amRNSAcquisition of Skill Boosters
14th Dec 202111:12 amRNSHolding(s) in Company
1st Dec 20212:00 pmRNSHalf Year Results Presentation Replay
1st Dec 20217:00 amRNSHalf Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.